Post by
NamesJeb on Dec 15, 2020 8:22am
Data
https://www.globenewswire.com/news-release/2020/12/15/2145345/0/en/Algernon-Pharmaceuticals-Announces-Positive-Trending-Interim-Data-for-its-Phase-2b-3-Ifenprodil-COVID-Study.html
Comment by
NamesJeb on Dec 15, 2020 8:30am
"(the Company or Algernon) a clinical stage pharmaceutical development company, is pleased to report, in a descriptive format, positive trending interim data for the Phase 2b part of the Companys Phase 2b/3 clinical study of Ifenprodil for COVID-19."
Comment by
SnoopDOdoubleG on Dec 15, 2020 8:42am
Emergency FDA approval based on the reduction of days in hospital will be extremely good for AGN and we shareholders. The Data set is very positive which will help us get to a new baseline until that happens. Patience is key....GLTA
Comment by
Biofinanace on Dec 15, 2020 8:56am
AGN becomes first Canadian company to share positive outcome from a covid therapeutic trial.